Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 945860, 6 pages
http://dx.doi.org/10.1155/2014/945860
Research Article

Clinical Utility of Ammonia Concentration as a Diagnostic Test in Monitoring of the Treatment with L-Asparaginase in Children with Acute Lymphoblastic Leukemia

1Department of Pediatric Oncology and Hematology, Children’s University Hospital, ul. Wielicka 265, 30-663 Krakow, Poland
2Department of Pediatric Oncology and Hematology, Polish American Institute of Pediatrics, Jagiellonian University Medical College, ul. Wielicka 265, 30-663 Krakow, Poland
3Department of Clinical Biochemistry, Polish American Institute of Pediatrics, Jagiellonian University Medical College, ul. Wielicka 265, 30-663 Krakow, Poland

Received 25 April 2014; Revised 7 July 2014; Accepted 11 July 2014; Published 23 July 2014

Academic Editor: Juan Manuel Mejía-Aranguré

Copyright © 2014 Małgorzata Czogała et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Prager and N. Bachynsky, “Asparagine synthetase in normal and malignant tissues; correlation with tumor sensitivity to asparaginase,” Archives of Biochemistry and Biophysics, vol. 127, pp. 645–654, 1968. View at Publisher · View at Google Scholar · View at Scopus
  2. F. F. Becker and J. D. Broome, “L-Asparaginase: inhibition of early mitosis in regenerating rat liver,” Science, vol. 156, no. 3782, pp. 1602–1603, 1967. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Konečná, B. Klejdus, and H. Hrstková, “Monitoring the asparaginase activity and asparagine levels in children with acute lymphoblastic leukaemia treated with different asparaginase preparations,” Scripta Medica, vol. 77, no. 2, pp. 55–62, 2004. View at Google Scholar · View at Scopus
  4. R. Riccardi, J. S. Holcenberg, D. L. Glaubiger, J. H. Wood, and D. G. Poplack, “L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans,” Cancer Research, vol. 41, pp. 4554–4558, 1981. View at Google Scholar · View at Scopus
  5. C. Rizzari, M. Citterio, M. Zucchetti et al., “A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia,” Haematologica, vol. 91, no. 1, pp. 24–31, 2006. View at Google Scholar · View at Scopus
  6. C. Rizzari, M. Zucchetti, V. Conter et al., “L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L- asparaginase as first exposure,” Annals of Oncology, vol. 11, no. 2, pp. 189–193, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Killander, A. Dohlwitz, L. Engstedt et al., “Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia,” Cancer, vol. 37, no. 1, pp. 220–228, 1976. View at Google Scholar
  8. J. P. V. Pinheiro and J. Boos, “The best way to use asparaginase in childhood acute lymphatic leukaemia—still to be defined?” The British Journal of Haematology, vol. 125, no. 2, pp. 117–127, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Gentili, V. Conter, C. Rizzari et al., “L-asparagine depletion in plasma and cerebrospinal fluid of children with acute lymphoblastic leukemia during subsequent exposures to Erwinia L-asparaginase,” Annals of Oncology, vol. 7, no. 7, pp. 725–730, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. H. J. Müller, R. Beier, L. Löning et al., “Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment,” British Journal of Haematology, vol. 114, no. 4, pp. 794–799, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. H. J. Müller, L. Löning, A. Horn et al., “Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols,” British Journal of Haematology, vol. 110, no. 2, pp. 379–384, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. M. H. Woo, L. J. Hak, M. C. Storm et al., “Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia,” Journal of Clinical Oncology, vol. 18, no. 7, pp. 1525–1532, 2000. View at Google Scholar · View at Scopus
  13. K. M. Heitink-Pollé, B. H. Prinsen, T. J. de Koning, P. M. van Hasselt, and M. B. Bierings, “High incidence of symptomatic hyperammonemia in children with acute lymphoblastic leukemia receiving pegylated asparaginase,” JIMD Reports, vol. 7, pp. 103–108, 2013. View at Google Scholar
  14. C. Jörck, W. Kiess, J. F. W. Weigel, U. Mütze, U. Bierbach, and S. Beblo, “Transient hyperammonemia due to L-asparaginase therapy in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma,” Pediatric Hematology and Oncology, vol. 28, no. 1, pp. 3–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. V. Leonard and J. D. S. Kay, “Acute encephalopathy and hyperammonaemia complicating treatment of acute lymphoblastic leukaemia with asparaginase,” The Lancet, vol. 1, no. 8473, pp. 162–163, 1986. View at Google Scholar · View at Scopus
  16. M. Steiner, A. Attarbaschi, U. Kastner et al., “Distinct fluctuations of ammonia levels during asparaginase therapy for childhood acute leukemia,” Pediatric Blood and Cancer, vol. 49, no. 5, pp. 640–642, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Watanabe, K. Miyake, C. Ogawa et al., “The ex vivo production of ammonia predicts l-asparaginase biological activity in children with acute lymphoblastic leukemia,” International Journal of Hematology, vol. 90, no. 3, pp. 347–352, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. K. Akobeng, “Understanding diagnostic tests 3: receiver operating characteristic curves,” Acta Paediatrica, vol. 96, no. 5, pp. 644–647, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. T. H. Jaing, J. L. Lin, Y. P. Lin, S. H. Yang, and S. H. Hsia, “Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia,” Journal of Pediatric Hematology/Oncology, vol. 31, no. 12, pp. 955–956, 2009. View at Publisher · View at Google Scholar · View at Scopus